Group 5/ 44 36 (81) -284% -321% 270 24 -91% Others 6/ (76) (72) (61) (113) (190) Profit attributable to owners of the Company 1,060 1,007 1,856 75% 84% 4,137 4,009 -3% Basic earnings per share (Baht) 0.77
rcent lower t million baht n increasing ues increas n. on baht, wh or an increa by 26.6 mill ivables incr mpany can e Company ue to the Co Ltd. 6 million b ar. This wa f interest in 52.4 million compare t
Shareholders ' Equity 251.63 202.01 49.62 24.56 Basic Loss Per Share (Baht) -0.36 -0.15 Gross Margin -1.71% 3.04% Net Profit Margin -132.08% -23.48% Debt to Equity Ratio (Time) 3.58 1.78 Total Expenses Summary
, a decline of Baht 1,366.26 million as compared to net profit of Baht 1,316.43 in the same period of the previous year. This was mainly due to reduced share of profit from investments in associated
(3) -103% Elimination (73) (41) 6 108% 115% (228) (134) 41% Profit attributable to owners of the Company 918 1,316 1,386 51% 5% 4,773 5,778 21% Basic earnings per share (Baht) 0.67 0.96 1.01 3.47 4.20
) 26.1 Share of Profit from Investments in Associates and Joint Ventures6 201.1 685.9 484.9 241.1 Income Tax (Expense) Income5 (17.1) (4.8) 12.3 (71.9) Profit attributable to Owners of the Parent 260.2
), trademark (THB 342 million), building and improvement (THB 54 million) and leasehold improvement (THB 23 million) The consolidated loss of YE 2018 is THB 345 million, increasing by 86% from last year (YE 2017
with chronic kidney disease. Present, patient who replacement therapy with dialysis with dialysis machines was increased steadily to fully capacity. Currently, there is still a plan for increasing the
Profit (Loss) (16.93) (2.20) 14.73 669.55 Earnings per share (Baht per share) (0.0032) (0.0005) 0.0027 540.00 Net Profit (Loss) The Company and subsidiaries (Consolidated) realized net loss of 16.93
% Finance costs for Q1/2024 compared to Q1/2023 increase 50.0% from Baht 43.6 million to Baht 65.4 million, increased by Baht 21.8 million. The increase mainly derived from continually increasing in MLR of